CMS Energy CMS
Utilities · Regulated Electric · Synthos Deep Dive · 2026-07-03
The Overview
CMS Energy is the parent of Consumers Energy, the company that delivers electricity and natural gas to about 1.9 million electric and 1.8 million gas customers across most of Michigan. It's a regulated utility — a government commission approves what it can charge, so its profits are steady and predictable, like a toll road for power. It pays a dividend of about 2.9% a year.
The catch: the stock is priced about right — not cheap, not expensive. You're paying a fair price for a safe, slow grower. Our verdict is Watch — there's nothing wrong with the company, but at today's price there isn't much upside to reach for, so it's a "keep an eye on it, buy on a dip" name rather than a buy-now.
Here's what our three scores mean in everyday terms:
- Downside Risk 4/10 (fairly low). The business is stable and the stock barely moves with the market, so it shouldn't crash — but it carries a lot of debt (normal for a utility) and isn't cheap, so the safety is only moderate.
- Growth Quality 5/10 (middle). It grows slowly and dependably, but it doesn't earn high returns on the money it invests — it's steady, not special.
- Exponential Potential 2/10 (low). This is a slow, regulated utility in one state. It will never double overnight, by design.
The one big worry: CMS depends on Michigan regulators letting it charge enough to earn a fair return and recover the billions it spends on the grid. A bad rate ruling, or higher interest rates on its large debt load, would pinch profits.
Putting a number on it: our fair-value estimate is $77 against a current price of $68.21 — real upside if our numbers are right.
Our summary metrics
Low beta (0.35) & regulated cash flows cushion downside, but 5.8× net-debt/EBITDA and 21× earnings leave little margin.
Steady ~7-8% EPS CAGR and rate-base growth, but low ROIC (3.6%) and no margin inflection — utility-grade, not high-quality growth.
Regulated single-state utility; ~5% revenue CAGR, decelerating, no multibagger optionality. Structurally capped.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Regulated single-state utility; ~5% revenue CAGR, decelerating, no multibagger optionality. Structurally capped.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $80 (high $83 / low $74; 17 Buy · 13 Hold · 0 Sell) — context, not our anchor |
| Valuation | 21× trailing EPS · 20× FY26E · 19× FY27E · 15× FY30E · EV/S 4.9× · EV/EBITDA 13.3× · div yield 2.9% |
| Technicals | Mild uptrend — $77.73, −2.8% off 52-wk high, above 50/200-DMA, RSI 70 (stretched), +10.8% 12-mo (SPY +20.6%) |
| Conviction | Low / none — 0 net-bullish voices, 0 KB claims. Call rests entirely on fundamentals & quant |
| Position sizing | If owned, a defensive income sleeve holding (~1–3%), not a growth position |
What the company says Issuer statements only — no independent expert coverage yet for CMS
“CMS's advance non-coverage of FDA-approved Alzheimer's drugs makes no sense; a clean phase 3 success will force reopening and reversal of that policy.”
These are the company’s own claims (management voices are always half-weighted in our scoring, never treated as independent validation) — shown because they’re the only claims on record for this name. Treat as company guidance, not third-party analysis.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $68.21, 7% below the 50-day average ($73), 7% below the 200-day average ($74) — a downtrend. 15% below the 52-week high of $80, 0% above the 52-week low of $68.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $68.21 is currently inside the band (band $68–$73).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 33.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.09, negative momentum.
Relative performance vs S&P 500 & its sector (XLU (sector)), set to 100 a year ago
Solid = CMS · dashed = S&P 500 · dotted = XLU (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
CMS Energy Corporation (NYSE: CMS) is a Jackson, Michigan-based energy holding company incorporated in 1987, whose principal business is Consumers Energy, a rate-regulated electric and gas utility serving most of Michigan's lower peninsula. It operates through three segments: Electric Utility (generation, distribution and sale of electricity — coal, wind, gas, renewables, oil and nuclear), Gas Utility (purchase, transmission, storage and distribution of natural gas), and NorthStar Clean Energy (independent power production and renewables marketing). It serves ~1.9 million electric and ~1.8 million gas customers and employs ~8,433 people. Fiscal year ends December 31.
Revenue mix (FY2025, from FMP product segmentation):
- By customer class: Residential $4.36B (60%) · Commercial $2.43B (33%) · Industrial $0.82B (11%). (These sum to the utility service revenue lines FMP breaks out; the residential tilt is a defensive feature — household demand is stickier and less cyclical than industrial load.)
- By geography: FMP provides no geographic segmentation — the business is essentially single-state (Michigan). That concentration is the whole story: one regulator (the Michigan Public Service Commission) sets the economics, which is both a stability anchor and the key risk (§11).
There is no meaningful international, product-diversification, or secular-growth angle here. This is a pure regulated-utility rate-base compounder: it spends capital on the grid, the regulator lets it earn a return on that capital, and earnings grow with the rate base.
2. The expert thesis (no coverage — stated plainly)
There is no expert coverage of CMS in the Synthos knowledge base. The claims file returns total_claims: 0, net_bullish_voices: 0, and an empty top array. No independent voice we track — bullish or bearish — has published a distilled, traceable view on this name.
What that means for this note, honestly: this verdict is entirely fundamentals- and quant-driven. There is no conviction-panel signal to lean on, and we will not manufacture one. Regulated utilities rarely attract the kind of thesis-driven expert commentary our KB indexes (they are cash-flow-and-regulation stories, not narrative stories), so the absence of coverage is itself unsurprising and is not, on its own, a negative signal. It simply means every judgment below rests on the reported financials, the analyst estimates (FMP), management's own guidance (§9), and the quant scoring framework — not on the Synthos expert panel. Weight this note accordingly.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 4 · Moderate-Low | Beta 0.35 and regulated, recession-resistant cash flows cushion the downside; offset by 5.8× net-debt/EBITDA (rate-sensitive) and a full 21× earnings multiple that leaves little valuation margin. |
| Growth Quality | 5 · Average | Dependable ~7–8% EPS CAGR and steady rate-base growth, but ROIC is only ~3.6% and ROE ~12% with no margin inflection — utility-grade reliability, not high-quality compounding. |
| Exponential Potential | 2 · Low | Single-state regulated utility; ~5% revenue / ~8% EPS CAGR that decelerates over the estimate window. No accelerating growth, no TAM expansion, no optionality — structurally capped by design. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Constructive Michigan rate cases, data-center / electrification load lifts rate-base growth to the high end; FY27E EPS reaches ~$4.30 and the multiple holds a premium ~20× on rate-quality earnings. | ~$86 (+11%) |
| Base (our anchor) | Estimates roughly hit — FY27E EPS ~$4.18; a dependable 6–8% grower with a 2.9% yield earns a market-utility ~18.5×. | ~$77 (≈ flat) |
| Bear | Adverse rate ruling or higher-for-longer rates compress the levered balance sheet; FY27E EPS slips to ~$4.05 and the multiple de-rates to ~15.5×. | ~$63 (−19%) |
Synthos fair value = the base case, ~$77 (≈ flat), with the full $63–$86 span as the honest range. Our anchor sits just below the Street's $80 consensus — we see the stock as roughly fairly priced rather than modestly cheap. The asymmetry is mildly unfavorable: ~+11% to the bull vs ~−19% to the bear. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). CMS is neither an exponential nor even a high-return compounder — it is a regulated rate-base grower, and we score it honestly low:
- Forward growth: revenue CAGR FY25→FY30E ~5.2% ($8.1B → $10.5B); EPS CAGR ~7.8% ($3.59 → $5.24). Solid for a utility, unremarkable in absolute terms.
- Acceleration (the 2nd derivative) is flat-to-negative: EPS growth runs ~8% (FY26E) → ~7.5% (FY27E) → ~8% (FY28E) → ~8% (FY29E) → ~8% (FY30E) — a deliberately steady, regulated ~7–8% band with no inflection. There is no acceleration to reward; management itself guides to a fixed 6–8% long-term rate (§9).
- Room to run: none in the exponential sense. CMS is a single-state regulated monopoly; its addressable market is Michigan's load, which grows with GDP/electrification, not with disruption. At a $24B cap it is neither small nor accelerating — a 2× would require ~15 years of compounding at guidance.
- The one genuine upside lever: grid electrification and potential data-center load growth in Michigan could lift the approved capital plan and rate base. That is real but incremental — it would move the growth rate by a point or two, not create a multibagger.
Exponential Potential: Low (2/10). Own CMS, if at all, for the dividend and stability, not for growth. This is the opposite end of the spectrum from a Synthos flagship candidate — and scoring it a 2 (not a default 5) is exactly the differentiation the framework demands.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $8.54B, +13.6% (FY24 $7.52B; FY23 $7.46B). Utility revenue is largely a pass-through of fuel and regulated rates, so top-line swings with weather and commodity costs more than with "growth" — don't over-read the +13.6%.
- Quarterly trajectory: Q1'25 $2.45B → Q2 $1.84B → Q3 $2.02B → Q4 $2.23B → Q1'26 $2.73B. Strongly seasonal (winter-heating and summer-cooling peaks); not a growth-acceleration signal.
- Margins: EBITDA margin ~36.6% TTM, operating ~19.5%, net ~12.5% TTM. Stable and regulator-set; no inflection expected.
- Earnings: net income $1.07B FY25 (EPS $3.53), up from $1.00B FY24 ($3.34) and $0.89B FY23 ($3.01) — the clean ~7–8% compounding the model is built on. Q1'26 EPS $1.13 adjusted (reaffirmed guidance).
- Cash flow (the key tell): operating CF $2.24B FY25, but capex −$3.82B (grid/rate-base investment) → free cash flow −$1.59B. FCF has been negative every year shown (−$0.65B FY24, −$0.91B FY23) because CMS out-invests its operating cash by design. This is normal for a growing regulated utility — the capex builds the rate base the regulator pays a return on — but it means growth is funded by continuous debt and equity issuance (FY25: +$2.4B net debt, +$0.53B stock), which dilutes and levers. Watch the financing mix, not FCF in isolation.
- Balance sheet: total debt $18.9B, net debt $18.3B, net-debt/EBITDA ~5.8× — high in absolute terms but standard for a regulated electric utility (regulators allow it against stable cash flows). Current ratio 0.84×. Interest coverage ~2.1× is adequate but not comfortable, which is why rate direction matters.
6. Valuation — priced in or room?
CMS trades at 21× trailing EPS, 4.9× EV/sales, 13.3× EV/EBITDA, and a 2.9% dividend yield — right in line with the regulated-utility peer group, neither a discount nor a premium. On live consensus the forward multiple steps down as expected earnings grow: 20× (FY26E) → 19× (FY27E) → 17× (FY28E) → 15× (FY30E). The PEG is unattractive at ~2.7× (21× trailing on ~8% growth), which is simply the reality of utilities in a moderate-rate world: you pay a bond-like multiple for bond-like growth plus a yield.
A simple dividend-plus-growth read: ~2.9% yield + ~7% EPS/dividend growth ≈ ~10% expected total return if the multiple holds — respectable, but fully dependent on no multiple compression, which is the rate-sensitivity risk. Street targets (context): consensus $80, high $83, low $74 — a tight ~12% band that itself signals "fairly valued, low dispersion." Our $77 base FV is a touch below consensus: we see the stock as trading at roughly fair value with balanced risk. Not a value buy; a fairly-priced-quality-utility hold.
7. Technicals (computed from EOD price history)
- Trend: mildly up. $77.73 sits above the 50-DMA ($74.12) and 200-DMA ($73.83), with the 50 just above the 200 — a constructive but shallow uptrend. MACD +1.06 (modestly positive).
- Location: −2.8% off the 52-week high ($79.94), +12.4% off the 52-week low ($69.17) — near the top of a narrow 52-week range, with a shallow max drawdown of just −2.8%. Low volatility, as expected.
- Momentum: RSI(14) 70.2 — at the overbought threshold. This is the one near-term caution flag: the name is technically stretched, arguing against chasing it here and for waiting for a pullback toward the ~$74 50-DMA.
- Relative strength: CMS +10.8% 12-mo vs SPY +20.6% and QQQ +30.3%; and −0.2% 3-mo vs SPY +13.7% — a defensive laggard. It has meaningfully underperformed the market, which is typical of utilities in a risk-on tape and consistent with its role as a low-beta ballast, not a leader.
- Read: technicals are benign but stretched. No trend problem, but RSI 70 near the range high means there is no urgency to buy today — a lower-risk entry sits back toward the rising 50-DMA.
8. Moat & competitive position
CMS's "moat" is regulatory, not competitive: as the regulated monopoly provider across most of lower-Michigan, it faces no direct competitor for its distribution franchise. That is durable but also a ceiling — its returns are capped by the Michigan Public Service Commission's allowed return on equity, so it cannot out-earn its regulator no matter how well it operates. The moat protects the downside (stable, monopoly cash flows) far more than it enables upside (returns are set, not won).
Peer set (market cap): the closest regulated-utility comparables are DTE Energy $32B (the other big Michigan utility and the truest peer), Southern Co $110B, Fortis $30B, Edison International $29B, FirstEnergy $28B, Evergy $20B, Alliant Energy $20B. CMS sits mid-pack on scale and valuation. Versus DTE — its in-state mirror — CMS carries a similar multiple and growth profile; there is no clear per-unit advantage that would justify a premium. The FMP peer list also includes non-comparable foreign names (Eletrobrás, Korea Electric) that we disregard.
9. Management, capital allocation & guidance
- Capital allocation: the entire model is reinvest-and-grow-the-rate-base — ~$3.8B/yr capex funded by operating cash plus continuous debt and equity issuance, while paying a growing dividend (payout ~63% of earnings). This is appropriate and standard for a regulated utility, but it means shareholders should expect modest ongoing equity dilution as a structural feature (FY25: +$0.53B stock issued), not a one-off.
- Insider activity: the sampled window (through 2026-06-16) is dominated by routine director/officer equity awards (grants, not open-market buys), plus one small open-market sale by an SVP (3,000 shares at $74.31, 2026-05-26). No cluster of alarming discretionary selling; a new CFO (Srikanth Maddipati) appears via Form 3 filings — a leadership transition worth noting but not a red flag.
- Management's own guidance (half-weighted — their own book): the SEC 8-K earnings release (filed 2026-04-28, Q1'26) is a real earnings release and states management's own forward guidance: CMS reaffirmed 2026 adjusted EPS guidance of $3.83–$3.90 and long-term adjusted EPS growth of 6–8%, "with continued confidence toward the high end." CEO Garrick Rochow cited "strong execution in the first quarter." Treat as management's self-interested framing (half-weight): the guidance is credible and consistent with the analyst estimates the base case uses, and the reaffirmation plus "high end" language is mildly positive — but it is exactly the kind of steady, on-plan messaging a well-run utility always issues. It confirms, rather than changes, the ~7–8% growth thesis.
10. Catalysts & what to watch
- Next earnings: 2026-07-30 (Q2'26; Street EPS $0.79 on ~$1.86B revenue — a seasonally lighter quarter). The key line: reaffirmation (or revision) of the $3.83–$3.90 FY26 guidance and the 6–8% long-term rate.
- Michigan rate cases: the single most important recurring catalyst — approved return on equity and capital-recovery decisions set the earnings trajectory. Constructive orders = bull case; adverse = bear.
- Interest-rate direction: with 5.8× net-debt/EBITDA and a ~2.9% yield, CMS trades partly like a bond proxy. Falling rates support the multiple and refinancing cost; rising rates pressure both.
- Load-growth optionality: any Michigan data-center or electrification demand that expands the approved capital plan — the one lever that could lift growth above the 6–8% band.
- Dividend: continued mid-single-digit dividend growth in line with EPS is the core of the total-return case.
Thesis tripwires (what would change the call): an adverse rate-case ruling that cuts allowed ROE; EPS guidance revised below the 6–8% band; net-debt/EBITDA drifting above ~6× without offsetting rate relief; or a multiple re-rating toward the low end of the peer group on higher rates.
11. Key risks
- Regulatory (structural, the dominant risk): single-state exposure to the Michigan Public Service Commission. An unfavorable rate case directly cuts allowed returns and the entire growth algorithm. No diversification to soften it.
- Leverage / rate sensitivity: 5.8× net-debt/EBITDA and ~2.1× interest coverage mean higher-for-longer rates raise financing costs and can compress the equity multiple. Utilities are among the most rate-sensitive equities.
- Persistently negative FCF: growth is funded by continuous debt and equity issuance; a capital-markets disruption or a spike in financing cost would strain the plan and dilute shareholders.
- Valuation / de-rating: at 21× trailing with ~8% growth (PEG ~2.7×), there is little cushion — a rotation out of defensives or a rate shock could de-rate the multiple even if earnings are fine.
- Weather / commodity / operational: earnings and revenue swing with Michigan weather and fuel costs; storm restoration, generation outages, or environmental-remediation costs are recurring operational risks.
- No expert coverage: we have zero independent KB voices on this name, so there is no thesis diversity backstopping the quant/fundamental read — a modest epistemic risk, disclosed.
12. Verdict, position sizing & monitoring
Watch. CMS is a well-run, low-beta, regulated Michigan utility delivering exactly what it promises — steady ~7–8% EPS growth, a reaffirmed $3.83–$3.90 FY26 guide, and a ~2.9% dividend. The problem is not quality; it is price. At ~$77 against a ~$77 base-case fair value and an $80 Street consensus, the stock is roughly fairly valued, with mildly unfavorable asymmetry (~+11% bull vs ~−19% bear) and an overbought (RSI 70) near-term technical setup. There is nothing to chase here and nothing broken to avoid — the definition of a Watch.
- Sizing: this is not a growth position. If held, it belongs in a defensive / income sleeve at a modest ~1–3% weight as low-beta ballast, ideally added on a pullback toward the ~$74 50-DMA rather than at the range high.
- Monitoring: re-underwrite on the tripwires in §10 — chiefly Michigan rate-case outcomes, the FY26 guidance track, leverage, and rate direction. Formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $77.73.
- Single biggest risk: Michigan regulatory outcomes on a 5.8×-levered balance sheet — the allowed return, not operations, sets the ceiling.
Provenance & disclosures
- Traceability: 0 KB claims — no expert coverage of CMS in the Synthos knowledge base. This note is fundamentals- and quant-driven; there is no conviction-panel signal, and none was fabricated. Every figure derives from FMP financials/estimates and the SEC 8-K guidance, all cited in-text.
- Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the 2026-04-28 SEC 8-K (Item 2.02). Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
- Management caveat: the $3.83–$3.90 FY26 guidance and 6–8% long-term rate are management's own, self-interested framing — half-weighted by design.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").